Videos

Carolyn D. Britten, MD, chief, Division of Hematology Oncology, associate director, Clinical Investigations, at the Hollings Cancer Center, Medical University of South Carolina, discusses questions that remain in immunotherapy.

Dr. Carolyn Britten on Next Steps in Immunotherapy

Articles

Britten continues as Associate Director for Clinical Investigations for the MUSC Hollings Cancer Center. 


Cancer Phase I Trials Expert Carolyn D. Britten, MD, Named Director of Hematology/Oncology Division for Medical University of South Carolina

International genome-Â­wide association study (GWAS) also identifies key gene responsible for expressing subtype of ovarian cancer.

International Team Including Hollings Cancer Center Scientist Finds Genetic Variants Key in Understanding Origins of Ovarian Cancer

New England Journal of Medicine Publishes Study Co-Led by Hollings Cancer Center Researcher Showing Potential of New Genomic Test In Lung Screening.

New Genomic Test Will Benefit Patients Being Screened for Lung Cancer

Dr. Matthew J. Carpenter, an associate professor at the Medical University of South Carolina and researcher with the MUSC Hollings Cancer Center, is the recipient of the 2015 Governor's Young Scientist Award for Excellence in Scientific Research.

Hollings Cancer Center Researcher Receives Prestigious Governor's Award for Science

Most oncologists do not regularly provide evidence-based tobacco cessation support for patients with cancer who smoke. However, addressing tobacco use is not as difficult as some might think. 

Hollings Cancer Center

Latest from Hollings Cancer Center

New content coming soon, please check back later.